Clinical Trials Logo

Bile Ductus Cancer clinical trials

View clinical trials related to Bile Ductus Cancer.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01016639 Completed - Colorectal Cancer Clinical Trials

Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer

CORGI
Start date: June 2003
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose with this study is to evaluate treatment with radio chemotherapy (oxaliplatin and capecitabine) given concommitant with radiotherapy in patients with gastrointestinal tumors. The trial consists ot two separate studies; CORGI-U in patients with stomach- bile ducts- gallbladder and pancreas cancer, and CORGI-L in patients with colorectal cancer. CORGI-U will be designed as a phase-I-II-study,in which the first part will be a chemotherapy dose finding study, followed by a phase II part to establish response rates. All subjects receives radiotherapy concommitant. CORGI-L is a phase II trial, in which patients are treated with chemotherapy at fixed doses with radiotherapy concommitant.